Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LATA-IBD Trial a Laparoscopic and Transanal IPAA-surgery Trial.

NCT07278687 is registered in ClinicalTrials.gov with Sahlgrenska University Hospital as lead sponsor.

NCT NCT07278687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07278687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LATA-IBD Trial a Laparoscopic and Transanal IPAA-surgery Trial.
Lead sponsor
Sahlgrenska University Hospital
Phase
Observational
Overall status
Completed
Start date
April 18, 2018
Completion date
March 30, 2023
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

familial adenomatous polyposis (fap), ulcerative colitis (disorder)